Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.
Gatell JM, González-Lahoz J, Clotet B, Antunes F, Kasparova L, Gil-Aguado A, Saballs P, Santamaria JM, Podzamczer D, Miro JM, Jou A, Verdejo J, Doroana M, Thomis J.
Gatell JM, et al. Among authors: podzamczer d.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):249-58. doi: 10.1097/00042560-199607000-00004.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996.
PMID: 8673528
Clinical Trial.